Increased myristate acid levels can enhance AMPK signalling in ovarian cancer cells because of myristoylation of the AMPK β-subunit (AMPKβ is specifically regulated by NMT1 rather than NMT2). Here, PRKAB1 is linked to ovarian cancer.